Journals / Klimik Dergisi / 2012 / Cilt: 25 - Sayı: 1

Bloody diarrhea-associated hemolytic uremic syndrome-thrombotic thrombocytopenic purpura: A case report

Kanlı ishal sonrası gelişen hemolitik üremik sendrom- trombotik trombositopenik purpura: Bir olgu sunumu

Pages
38–40
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herewith, we have reviewed the relevant literature on HUS-TTP and emphasized that plasmapheresis- based treatment for TTP may be life-saving even though treatment of HUS is symptomatic.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP) are termed HUS-TTP since their clinical features are alike.
📊
Key Findings & Data:A 42-year-old female with abdominal pain and bloody diarrhea for two days was admitted to the hospital.
💡
Conclusion & Impact:Herewith, we have reviewed the relevant literature on HUS-TTP and emphasized that plasmapheresis- based treatment for TTP may be life-saving even though treatment of HUS is symptomatic.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP) are termed HUS-TTP since their clinical features are alike. A 42-year-old female with abdominal pain and bloody diarrhea for two days was admitted to the hospital. She had a history of antibiotic therapy ten days before for upper respiratory tract infection. At physical examination, body temperature was 36.6°C and she had abdominal tenderness, but other systems were normal. During follow up, the patient developed hemolytic anemia, thrombocytopenia and acute renal failure which led to HUS-TTP. Stool examination did not reveal any microorganism or verotoxin. Due to the worsening clinical status and laboratory findings, plasmapheresis was performed. Shortly after plasmapheresis, the patient survived and renal failure resolved completely. Herewith, we have reviewed the relevant literature on HUS-TTP and emphasized that plasmapheresis- based treatment for TTP may be life-saving even though treatment of HUS is symptomatic.

Özet

Hemolitik üremik sendrom (HÜS) ve trombotik trombositopenik purpura (TTP), klinik özellikleri örtüştüğü için erişkinlerde genelikle HÜS-TTP olarak da adlandırılmaktadır. 42 yaşındaki kadın, iki gündür olan karın ağrısı ve kanlı dışkılama şikayetleriyle başvurdu. Yaklaşık 10 gün önce üst solunum yolu infeksiyonuna yönelik antibiyotik tedavisi aldığı öğrenildi. Vücut sıcaklığı 36.6°C idi ve karında hassasiyeti vardı. Diğer sistemlerin muayenesi normaldi. Takiplerinde hemolitik anemi, trombositopeni ve akut böbrek yetmezliği gelişen hastaya HÜS-TTP tanısı konuldu. Dışkı incelemesinde patojen bir mikroorganizma ve verotoksin saptanmadı. Destek tedavisine rağmen klinik tablosunun kötüleşmesi ve laboratuvar testlerinin bozulması üzerine steroid ve plazmaferez uygulandı. Bu tedavi sonrası hasta iyileşti ve böbrek fonksiyonları normal sınıra geldi. Bu yazıda HÜS ve TTP ile ilgili literatür gözden geçirilerek tedavisi semptomatik olan HÜS ile birlikte TTPli hastalara uygulanan plazmaferez temelli tedavilerin yaşam kurtarıcı olabildiği vurgulanmaktadır.

🔖

Cite This Article

ERDOĞAN, A., YILMAZ, K. U., ERDOĞAN, H. (2022). Bloody diarrhea-associated hemolytic uremic syndrome-thrombotic thrombocytopenic purpura: A case report. Klimik Dergisi, Cilt: 25 - Sayı: 1, 38–40. https://ajindex.com/articles/573634

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. George JN. The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: overview of pathogenesis (Experience of The Oklahoma TTP-HUS Registry, 1989-2007). Kidney Int [Suppl.]. 2009
  2. S8-10. [CrossRef] 2. Tarr PI. Shiga toxin-associated hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: distinct mechanisms of pathogenesis. Kidney Int [Suppl.]. 2009
  3. : S29-32. [CrossRef] 3. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005
  4. 365(9464): 1073-86. [CrossRef] 4. Michael M, Elliott EJ, Ridley GF, Hodson EM, Craig JC. Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. Cochrane Database Syst Rev. 2009
  5. : CD003595. 5. Erdoğan H, Erdoğan A, Levent B, Kayali R, Arslan H. Enterohemorrhagic Escherichia coli O157:H7: case report. Turk J Pediatr. 2008
  6. 50(5): 488-91. 6. Frank C, Werber D, Cramer JP, et al. Epidemic profile of Shigatoxin- producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med. 2011
  7. 365(19): 1771-80. [CrossRef] 7. Karpac CA, Li X, Terrell DR, et al. Sporadic bloody diarrhoeaassociated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. Br J Haematol. 2008
  8. 141(5): 696-707. [CrossRef] 8. Erdoğan H, Levent B, Erdoğan A, Güleşen R, Arslan H. Gastroenteritli olgularda verotoksijenik Escherichia coli O157:H7 insidansının araştırılması. Mikrobiyol Bül. 2011
  9. 45(3): 519-25. 9. Panos GZ, Betsi GI, Falagas ME. Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection? Aliment Pharmacol Ther. 2006
  10. 24(5): 731-42. [CrossRef] 10. Shibagaki Y, Fujita T. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other? Hypertens Res. 2005
  11. 28(1): 89-95. [CrossRef] 11. Tostivint I, Mougenot B, Flahault A, et al. Adult haemolytic and uraemic syndrome: causes and prognostic factors in the last decade. Nephrol Dial Transplant. 2002
  12. 17(7): 1228-34. [CrossRef]